Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Newborn | 14 | 2015 | 972 | 0.230 |
Why?
|
| Respiratory Syncytial Virus Infections | 3 | 2015 | 17 | 0.220 |
Why?
|
| Infant, Premature | 3 | 2013 | 134 | 0.180 |
Why?
|
| Infant, Very Low Birth Weight | 3 | 2013 | 50 | 0.180 |
Why?
|
| Nanostructures | 1 | 2022 | 161 | 0.160 |
Why?
|
| Biosensing Techniques | 1 | 2022 | 136 | 0.160 |
Why?
|
| Colorectal Neoplasms | 1 | 2022 | 512 | 0.120 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2013 | 41 | 0.110 |
Why?
|
| Puerto Rico | 7 | 2015 | 1413 | 0.100 |
Why?
|
| Stiff-Person Syndrome | 1 | 2013 | 2 | 0.100 |
Why?
|
| Neutropenia | 1 | 2013 | 11 | 0.100 |
Why?
|
| Infant, Small for Gestational Age | 1 | 2013 | 19 | 0.100 |
Why?
|
| Thrombocytopenia | 1 | 2013 | 23 | 0.100 |
Why?
|
| Cytomegalovirus Infections | 1 | 2013 | 28 | 0.090 |
Why?
|
| Ichthyosis, Lamellar | 1 | 2012 | 2 | 0.090 |
Why?
|
| Propionic Acidemia | 1 | 2012 | 2 | 0.090 |
Why?
|
| Noonan Syndrome | 1 | 2012 | 3 | 0.090 |
Why?
|
| Twins, Dizygotic | 1 | 2012 | 9 | 0.090 |
Why?
|
| Diseases in Twins | 1 | 2012 | 7 | 0.090 |
Why?
|
| Oseltamivir | 1 | 2012 | 9 | 0.090 |
Why?
|
| Neonatology | 1 | 2012 | 7 | 0.090 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2012 | 22 | 0.090 |
Why?
|
| Pre-Eclampsia | 1 | 2013 | 67 | 0.090 |
Why?
|
| Influenza A Virus, H1N1 Subtype | 1 | 2012 | 24 | 0.090 |
Why?
|
| Infant, Low Birth Weight | 1 | 2012 | 36 | 0.090 |
Why?
|
| Antiviral Agents | 2 | 2012 | 195 | 0.090 |
Why?
|
| Infant | 6 | 2015 | 1175 | 0.090 |
Why?
|
| Infant, Premature, Diseases | 1 | 2012 | 65 | 0.090 |
Why?
|
| Delivery Rooms | 1 | 2011 | 4 | 0.090 |
Why?
|
| Epinephrine | 1 | 2011 | 36 | 0.090 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2011 | 24 | 0.090 |
Why?
|
| Pneumonia, Viral | 1 | 2013 | 88 | 0.080 |
Why?
|
| Influenza, Human | 1 | 2012 | 92 | 0.080 |
Why?
|
| Heart Arrest | 1 | 2011 | 52 | 0.080 |
Why?
|
| Substance-Related Disorders | 2 | 2008 | 830 | 0.080 |
Why?
|
| Brain Abscess | 1 | 2010 | 2 | 0.080 |
Why?
|
| Meningitis, Fungal | 1 | 2010 | 4 | 0.080 |
Why?
|
| Candidiasis | 1 | 2010 | 89 | 0.070 |
Why?
|
| Retrospective Studies | 6 | 2015 | 2544 | 0.070 |
Why?
|
| Maternal Behavior | 1 | 2008 | 29 | 0.070 |
Why?
|
| Lymphangioma | 1 | 2008 | 5 | 0.070 |
Why?
|
| Thrombocytosis | 1 | 2008 | 5 | 0.070 |
Why?
|
| Hemangioma | 1 | 2008 | 7 | 0.070 |
Why?
|
| Neoplasms, Multiple Primary | 1 | 2008 | 14 | 0.070 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2008 | 20 | 0.070 |
Why?
|
| Evidence-Based Medicine | 1 | 2008 | 107 | 0.070 |
Why?
|
| Kidney Neoplasms | 1 | 2008 | 80 | 0.070 |
Why?
|
| Weight Gain | 1 | 2008 | 139 | 0.070 |
Why?
|
| Humans | 16 | 2022 | 43102 | 0.060 |
Why?
|
| Pregnancy Complications | 1 | 2008 | 140 | 0.060 |
Why?
|
| Bronchiolitis | 1 | 2005 | 2 | 0.060 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2005 | 8 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 2 | 2022 | 306 | 0.050 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2002 | 8 | 0.050 |
Why?
|
| Porosity | 1 | 2022 | 43 | 0.050 |
Why?
|
| Electrochemical Techniques | 1 | 2022 | 32 | 0.050 |
Why?
|
| Microfluidics | 1 | 2022 | 45 | 0.050 |
Why?
|
| Limit of Detection | 1 | 2022 | 94 | 0.050 |
Why?
|
| Immunoassay | 1 | 2022 | 74 | 0.050 |
Why?
|
| Male | 9 | 2013 | 23409 | 0.040 |
Why?
|
| Female | 9 | 2013 | 24698 | 0.040 |
Why?
|
| Pregnancy | 3 | 2013 | 1772 | 0.040 |
Why?
|
| Seasons | 1 | 2015 | 139 | 0.030 |
Why?
|
| Follow-Up Studies | 2 | 2011 | 1067 | 0.030 |
Why?
|
| Fatal Outcome | 1 | 2013 | 48 | 0.020 |
Why?
|
| History, 21st Century | 1 | 2012 | 83 | 0.020 |
Why?
|
| History, 20th Century | 1 | 2012 | 121 | 0.020 |
Why?
|
| Sympathomimetics | 1 | 2011 | 8 | 0.020 |
Why?
|
| Young Adult | 2 | 2013 | 5080 | 0.020 |
Why?
|
| Incidence | 1 | 2013 | 1078 | 0.020 |
Why?
|
| Adolescent | 2 | 2013 | 6081 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2008 | 3156 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2011 | 1604 | 0.020 |
Why?
|
| Adult | 2 | 2013 | 13872 | 0.010 |
Why?
|
| Prevalence | 1 | 2008 | 1612 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2008 | 1759 | 0.010 |
Why?
|
| Erythema | 1 | 2002 | 10 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 2002 | 21 | 0.010 |
Why?
|
| Exanthema | 1 | 2002 | 12 | 0.010 |
Why?
|
| Immunization | 1 | 2002 | 94 | 0.010 |
Why?
|
| Fever | 1 | 2002 | 62 | 0.010 |
Why?
|
| Risk Factors | 1 | 2008 | 3994 | 0.010 |
Why?
|
| Pain | 1 | 2002 | 290 | 0.010 |
Why?
|
| Hospitalization | 1 | 2002 | 485 | 0.010 |
Why?
|